The development of a gut-specific immune response to an oral antigen is dependent on&#160;α4β7&#160;mediated lymphocyte trafficking

S-pindolol (ACM-001) - Actimed Therap

Entyvio (vedolizumab) - Takeda

https://plan.core-apps.com/aai2022/event/e9992ea20c9220e993d8a15da10e3a45

Allison L Sang1;Naresh S Redhu1;Dooyoung Lee1;Fyonn Dhang1;Raegan Bonesteel1;Sarah St. Gelais1;Cheng Zhong1;Dan Cui1;Bryce Harrison1;Dawn Troast1;Matthew G Bursavich1;Blaise Lippa1;Bruce N Rogers1;Adrian S Ray1;Jamie Wong1

Apr 8, 2022